Alexander Knuth, M.d.
Vice President for Healthcare Outcomes Policy and
Oncology and Molecular Radiation Sciences
Hamad Medical Corporation
Norway
Biography
Dr. Alexander Knuth is the medical director and chief executive officer of the National Center for Cancer Care and Research at Hamad Medical Corporation.Dr. Knuth’s pioneering work in cancer immunology led to the discovery of multiple human cancer antigens including MAGE, the first of the so-called cancer/testis (CT) antigens that have been a primary target of vaccine strategies to date. He also played a pivotal role in the development of peptide-based vaccines and adjuvants, established immune-monitoring techniques, and discovered tumor escape mechanisms. He has received many awards, including the prestigious Johann-Georg-Zimmermann Medal.
Research Interest
In addition to being a member of CRI’s Scientific Advisory Council, Dr. Knuth serves on the CLIP Grant Review Committee and is a member of CRI’s global clinical investigator network.
